It has been reported that butyrate alleviates steatohepatitis by limiting inflammatory macrophage activity [55] and may have beneficial effects on MASLD through inhibition of NF-κB nuclear translocation and modulation of inflammatory signaling [56]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.